Epigallocatechin-3-Gallate (EGCG): A Structural Target for the Development of Potential Therapeutic Drugs Against Anti-Proliferative Diseases

By  

Drug Design Reviews - Online, Vol. 2, Iss. 1, 2005-02 ,pp. : 85-91

Bentham Science Publishers

Access to resources Recommend Favorite

(−)-Epigallocatechin-3-gallate induces contraction of the rat aorta by a calcium influx-dependent mechanism

By Álvarez-Castro Ezequiel   Campos-Toimil Manuel   Orallo Francisco  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 5, 2004-05 ,pp. : 496-506

Springer Publishing Company

Access to resources Recommend Favorite

Compounds Derived from Epigallocatechin-3-Gallate (EGCG) as a Novel Approach to the Prevention of Viral Infections

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 14, Iss. 1, 2015-02 ,pp. : 13-18

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer activities of (−)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells

By de Pace Rita Castillo Cohen   Liu Xinli   Sun Ming   Nie Shufang   Zhang Jia   Cai Qingsong   Gao Weimin   Pan Xuan   Fan Zhaoyang   Wang Shu  

Journal of Liposome Research, Vol. 23, Iss. 3, 2013-09 ,pp. : 187-196

Informa Healthcare

Access to resources Recommend Favorite

Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines

By  

Current Cancer Drug Targets, Vol. 16, Iss. 4, 2016-04 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite